# Cellectis (CLLS) — Earnings

CLLS · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/clls/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.22 |
| EPS estimate | −$0.24 |
| EPS surprise | +6.86% |
| Revenue surprise | −36.51% |
| Revenue | $6.9M |
| Revenue estimate | $10.9M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1627281/000119312526338220/clls_6-k_q2_2026.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.24 | −$0.22 | 6.86% | $10.9M | $6.9M |
| Q1 2026 | May 11, 2026 | −$0.22 | −$0.18 | 19.39% | $8.9M | $7.5M |
| Q4 2025 | Mar 20, 2026 | −$0.20 | −$0.26 | -27.89% | $13.4M | $12.2M |
| Q3 2025 | Nov 7, 2025 | −$0.23 | $0.01 | 104.32% | $9.6M | $37.2M |
| Q2 2025 | Aug 4, 2025 | −$0.21 | −$0.24 | -12.15% | $11.2M | $18.2M |
| Q1 2025 | May 12, 2025 | −$0.15 | −$0.18 | -16.88% | $13.8M | $12.0M |
| Q4 2024 | Mar 14, 2025 | −$0.18 | −$0.17 | 8.06% | $9.9M | $33.2M |
| Q3 2024 | Nov 4, 2024 | −$0.20 | −$0.23 | -13.24% | $9.8M | $18.1M |
| Q2 2024 | Aug 6, 2024 | −$0.29 | −$0.28 | 2.34% | $3.7M | $9.5M |
| Q1 2024 | May 28, 2024 | −$0.33 | $0.08 | 124.24% | $3.7M | $6.5M |
| Q4 2023 | Apr 29, 2024 | −$0.20 | −$0.64 | -228.21% | $1.8M | $2.0M |
| Q3 2023 | Nov 6, 2023 | −$0.42 | −$0.31 | 25.84% | $3.4M | $1.6M |
| Q2 2023 | Aug 3, 2023 | −$0.44 | −$0.19 | 56.66% | $4.5M | $2.0M |
| Q1 2023 | May 4, 2023 | −$0.48 | −$0.58 | -20.48% | $6.0M | $3.6M |
| Q4 2022 | Mar 6, 2023 | −$0.60 | −$0.59 | 1.01% | $18.6M | $17.3M |
| Q3 2022 | Nov 3, 2022 | −$0.45 | −$0.63 | -41.16% | $16.9M | $1.9M |
| Q2 2022 | Aug 4, 2022 | −$0.51 | −$0.42 | 18.35% | $23.5M | $2.8M |
| Q1 2022 | May 12, 2022 | −$0.67 | −$0.70 | -4.85% | $18.6M | $3.8M |
| Q4 2021 | Mar 3, 2022 | −$0.92 | −$0.55 | 39.96% | $9.9M | $13.7M |
| Q3 2021 | Nov 4, 2021 | −$0.83 | −$0.82 | 1.30% | $11.1M | $10.8M |

## Frequently Asked Questions

### When did Cellectis (CLLS) last report earnings?

Cellectis last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did CLLS beat earnings estimates?

Yes. Cellectis reported EPS of −$0.22 for Q2 2026 against a −$0.24 estimate — a 6.86% beat.

### How much revenue did CLLS report last quarter?

Cellectis reported $6.9M in revenue for Q2 2026, against a consensus estimate of $10.9M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).